Candida is a lees fungus, a fungus and a lees. A very resilient creature. We are coming with contact with it all the time, every where, by the air and by our food.  If our immune system was in order then the fungus would have no effect of our lives. We would have swallow it, destroy it, and get it out of our body with everything else.

Candida is a lees fungus, a fungus and a lees. A very resilient creature. We are coming with contact with it all the time, every where, by the air and by our food. If our immune system was in order then the fungus would have no effect of our lives. We would have swallow it, destroy it, and get it out of our body with everything else.

Di-Gize essential oil blend “relieves digestive problems including indigestion, heartburn, gas, & bloating. Combats candida (yeast) & parasite infection. It is great for morning sickness & nausea during pregnancy!    ➤ Put a few drops in a glass of water & drink it.  ➤ Put Di-Gize essential oil blend in a capsule & swallow as a supplement.  ➤ Apply it directly on your stomach,   ➤ Apply it to the bottoms of your feet on the stomach-vita-flex points

Di-Gize essential oil blend “relieves digestive problems including indigestion, heartburn, gas, & bloating. Combats candida (yeast) & parasite infection. It is great for morning sickness & nausea during pregnancy! ➤ Put a few drops in a glass of water & drink it. ➤ Put Di-Gize essential oil blend in a capsule & swallow as a supplement. ➤ Apply it directly on your stomach, ➤ Apply it to the bottoms of your feet on the stomach-vita-flex points

Entamoeba histolyca

Entamoeba histolyca

Self-injectable Tocilizumab was approved by the EU late April 2014 to specifically treat adult patients with moderate or severe Rheumatoid arthritis (RA) who have failed to respond to other medications or who are intolerant to prior treatments. RoACTEMRA is the 1st and only anti IL-6 receptor biologic offered as both an IV treatment and a subcutaneous injection to be used alone or in combination with Methotrexate. The approval was based on two Phase 3 trials coined BREVACTA and SUMMACTA.

Self-injectable Tocilizumab was approved by the EU late April 2014 to specifically treat adult patients with moderate or severe Rheumatoid arthritis (RA) who have failed to respond to other medications or who are intolerant to prior treatments. RoACTEMRA is the 1st and only anti IL-6 receptor biologic offered as both an IV treatment and a subcutaneous injection to be used alone or in combination with Methotrexate. The approval was based on two Phase 3 trials coined BREVACTA and SUMMACTA.

Pinterest
Search